Skip to main content

Table 3 Subgroup analysis by singleton pregnancy

From: A case-control study on the effects of incomplete, one, and more than one dexamethasone course on acute respiratory problems in preterm neonates born between 280 and 366 weeks of gestation

Outcomes

Total (N = 1585)

<  1 course (n = 673): (1)

1 course (n = 783): (2)

>  1 course (n = 129): (3)

P value

Adjusted odds ratio (95% CI) for < 1 course

Adjusted odds ratio (95% CI) for >  1 course

Neonatal

 APGAR score < 7 (1 min)

269 (17.0%)

96 (14.3%)

140 (17.9%)

33 (25.6%)

0.005ab

0.777 (0.584–1.034)

1.499 (0.962–2.336)

 APGAR score < 7 (5 min)

78 (4.9%)

33 (4.9%)

35 (4.5%)

10 (7.8%)

0.279

1.139 (0.697–1.859)

1.899 (0.907–3.976)

 Post-natal adaptation

66 (4.2%)

23 (3.4%)

39 (5.0%)

4 (3.1%)

0.271

0.703 (0.414–1.193)

0.627 (0.219–1.799)

 Bronchopulmonary dysplasia

45 (2.8%)

18 (2.7%)

22 (2.8%)

5 (3.9%)

0.752

0.929 (0.487–1.769)

1.376 (0.504–3.761)

 Pneumonia

54 (3.4%)

15 (2.2%)

29 (3.7%)

10 (7.8%)

0.005ab

0.609 (0.322–1.148)

2.516 (1.179–5.371)

 Pneumothorax

30 (1.9%)

9 (1.3%)

19 (2.4%)

2 (1.6%)

0.301

0.552 (0.247–1.237)

0.757 (0.173–3.324)

 Intraventricular haemorrhage

61 (3.8%)

23 (3.4%)

29 (3.7%)

9 (7.0%)

0.15

0.908 (0.515–1.600)

1.838 (0.840–4.023)

 Necrotising enterocolitis

45 (2.8%)

12 (1.8%)

28 (3.6%)

5 (3.9%)

0.041c

0.515 (0.258–0.982)

1.002 (0.372–2.701)

 Neonatal death

34 (2.1%)

14 (2.1%)

16 (2.0%)

4 (3.1%)

0.736

0.997 (0.479–2.076)

1.569 (0.504–4.884)

 Sepsis

145 (9.1%)

48 (7.1%)

76 (9.7%)

21 (16.3%)

0.003ab

0.729 (0.499–1.065)

1.785 (1.050–3.034)

 Hypothermia

41 (2.6%)

17 (2.5%)

18 (2.3%)

6 (4.7%)

0.294

1.144 (0.582–2.247)

2.033 (0.778–5.311)

 Phototherapy

917 (57.9%)

370 (55.0%)

450 (57.5%)

97 (75.2%)

<  0.001ab

0.928 (0.752–1.145)

2.180 (1.420–3.349)

 Transient tachypnoea of the newborn

344 (21.7%)

141 (21.0%)

163 (20.8%)

40 (31.0%)

0.028ab

1.001 (0.775–1.292)

1.719 (1.134–2.606)

 Ventilator support

194 (12.2%)

89 (13.2%)

82 (10.5%)

23 (17.8%)

0.036a

1.281 (0.928–1.768)

1.861 (1.115–3.107)

 Continuous positive airway pressure

320 (20.2%)

117 (17.4%)

166 (21.2%)

37 (28.7%)

0.008b

0.786 (0.603–1.025)

1.448 (0.948–2.210)

 Positive pressure ventilation

201 (12.7%)

88 (13.1%)

86 (11.0%)

27 (20.9%)

0.007a

1.257 (0.912–1.731)

2.140 (1.313–3.486)

 Intermediate care unit admission

1107 (69.8%)

491 (73.0%)

549 (70.1%)

67 (51.9%)

<  0.001ab

1.137 (0.903–1.432)

0.474 (0.323–0.695)

 Neonatal intensive care unit admission

344 (21.7%)

133 (19.8%)

164 (20.9%)

47 (36.4%)

<  0.001ab

0.946 (0.730–1.225)

2.160 (1.444–3.232)

 Respiratory distress syndrome

72 (4.5%)

34 (5.1%)

29 (3.7%)

9 (7.0%)

0.179

1.372 (0.824–2.283)

1.776 (0.812–3.886)

 Persistent tachypnoea of the newborn

1 (0.1%)

1 (0.1%)

0 (0.0%)

0 (0.0%)

0.508

 Length of hospital stay (days)

7 (1–179)

6 (1–179)

7 (1–179)

14 (1–179)

<  0.001abc

 Mean neonatal weight (grams)

2245.5 ± 568.5

2327.9 ± 573.6

2219.1 ± 556.7

1975.6 ± 515.3

<  0.001abc

Maternal

     

 Gestational age at delivery (weeks of gestation)

34.5 ± 2.1

34.8 ± 2.0

34.4 ± 2.1

33.4 ± 2.0

<  0.001abc

Underlying disease

 Diabetes mellitus (DM)

28 (1.8%)

11 (1.6%)

14 (1.8%)

3 (2.3%)

0.842

0.913 (0.412–2.204)

1.308 (0.371–4.616)

 Hypertension

102 (6.4%)

37 (5.5%)

45 (5.7%)

20 (15.5%)

< 0.001ab

0.954 (0.610–1.493)

3.009 (1.712–5.288)

 Others

153 (9.7%)

55 (8.2%)

78 (10.0%)

20 (15.5%)

0.034b

0.804 (0.560–1.155)

1.658 (0.975–2.821)

Length of hospital stay (days)

6 (2–143)

5 (2–31)

7 (2–56)

12 (2–143)

<  0.001abc

Puerperal infection

11 (0.7%)

5 (0.7%)

5 (0.6%)

1 (0.8%)

0.965

1.165 (0.336–4.040)

1.216 (0.141–10.490)

Referral to other centres

21 (1.3%)

5 (0.7%)

13 (1.7%)

3 (2.3%)

0.182

0.443 (0.157–1.250)

1.410 (0.396–5.019)

  1. Chi-square test with multiple comparison by Bonferroni correction was used to compare the categorical outcome between groups
  2. Kruskal-Wallis test with Dunn’s test correction for multiple comparison was used to compare the non-normally distributed continuous data between groups
  3. One-way ANOVA with Bonferroni correction for multiple comparison was used to compare the normally distributed continuous data between groups
  4. Multivariable logistic regression models were used to calculate the adjusted odds ratios and 95% confidence intervals (95% CI) to examine the association between steroid groups and adverse outcomes after adjusting for covariate (maternal age, BMI, morbidities)
  5. aStatistically significant between 2 and 3
  6. bStatistically significant between 1 and 3
  7. cStatistically significant between 1 and 2